glp 1 gastric issues GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH GLP-1 and Gut Health: Addressing
Description
Both drugs are generally avoided in pregnancy and certain rare personal or family histories of medullary thyroid cancer, and the doctor will review the history before prescribing
Interestingly, some reports suggest retatrutide's balanced receptor activation may produce fewer GI issues than equivalent weight loss from single agonists, though this requires further investigation
As previously mentioned nausea is common but vomiting is not acceptable
doi: 10.3389/fnbeh.2020.614884
Conservar en lugar fresco y seco, protegido de la humedad y la luz directa
doi: 10.1056/NEJMoa2407379
